SPP1, secreted phosphoprotein 1, 6696

N. diseases: 824; N. variants: 13
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0221106
Disease: Alkalemia
Alkalemia
0.010 AlteredExpression disease BEFREE Osteogenic markers as ALP, OPN, and OC mRNA were higher expressed in increasing pH values throughout osteoblastogenesis. 31531354 2019
CUI: C0233794
Disease: Memory impairment
Memory impairment
0.010 Biomarker phenotype BEFREE Behavior tests showed impaired memory and learning ability in OPN<sup>-</sup> OPN<sup>+/+</sup> pups. 30199283 2019
CUI: C0235989
Disease: Renal interstitial fibrosis
Renal interstitial fibrosis
0.010 AlteredExpression disease BEFREE CL treatment improved TAC-induced renal dysfunction and decreased renal interstitial fibrosis (reduced expression of e-cadherin and TGFβ-1) and interstitial inflammation (decreased infiltration of ED-1-positive and osteopontin-positive cells). 31200653 2019
CUI: C0241397
Disease: Triphalangeal thumb
Triphalangeal thumb
0.010 Biomarker disease BEFREE In conclusion, ZLN and TPT treatments are safe on carotid walls in osteoporotic women with subclinical atherosclerosis; circulating OPG and OPN are not affected by long-term anti-osteoporotic treatments and do not correlate with CA-IMT. 30791743 2019
CUI: C0242339
Disease: Dyslipidemias
Dyslipidemias
0.010 Biomarker group BEFREE OPN and OPG positively correlated with greater systolic blood pressure (SBP) values, HOMA-IR and HOMA-β, and with the presence of dyslipidemia and carotid atherosclerosis. 30132286 2019
CUI: C0264694
Disease: Chronic myocardial ischemia
Chronic myocardial ischemia
0.010 Biomarker disease BEFREE Osteopontin - a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease. 30843743 2019
CUI: C0264714
Disease: Acute heart failure
Acute heart failure
0.010 Biomarker disease BEFREE We highlight date from recent studies examining the use of novel biomarkers (micro RNAs, osteopontin, insulin-like growth-factor binding protein-7) for the diagnosis of AHF. 30547895 2019
Familial Cerebral Amyloid Angiopathy
0.010 Biomarker disease BEFREE We propose that calcification of CAA vessels in the observed HCHWA-D cases may be induced by extracellular OPN trapped in the fibrotic Col1 vessel wall, independently of the presence of vascular amyloid. 30868685 2019
Hepatic methionine adenosyltransferase deficiency
0.010 AlteredExpression disease BEFREE Increased matrix metalloproteinase-2 (MMP-2), osteopontin, and interleukin-6 expression was detected in HMet + PPE rats. 31307051 2019
CUI: C0282193
Disease: Iron Overload
Iron Overload
0.010 AlteredExpression disease BEFREE Icariin could protect against iron overload-induced mitochondrial membrane potential dysfunction and ROS production, promote osteoblast survival and reverse the reduction of Runx2, alkaline phosphatase, and osteopontin expression induced by iron overload. 30387158 2019
CUI: C0334533
Disease: Arteriovenous hemangioma
Arteriovenous hemangioma
0.010 AlteredExpression disease BEFREE Expression of osteopontin, matrix metalloproteinase-2 and -9 proteins in vascular instability in brain arteriovenous malformation. 31275742 2019
CUI: C0340643
Disease: Dissection of aorta
Dissection of aorta
0.010 Biomarker disease BEFREE The aim of this study was to explore the relationship between osteopontin (OPN) and AD. 30626766 2019
CUI: C0409952
Disease: Idiopathic osteoarthritis
Idiopathic osteoarthritis
0.010 Biomarker disease BEFREE Genes involved in bone formation and mineralization, such as osteopontin (OPN) and Matrix Gla protein (MGP), could also be related with OA. 29777408 2019
CUI: C0410438
Disease: Primary osteoporosis
Primary osteoporosis
0.010 Biomarker disease BEFREE Bone metabolism-related molecules, such as alkaline phosphatase, matrix Gla protein, osteocalcin, osteopontin, and collagen type I; inflammatory cytokines, such as interleukin-1, -6, and tumor necrosis factor; and lipid metabolism related molecules, such as oxidized low density lipoprotein; mediate signaling in primary osteoporosis and vascular calcification. 28958683 2019
CUI: C0428791
Disease: Aortic valve calcification
Aortic valve calcification
0.010 Biomarker disease BEFREE <b>NEW & NOTEWORTHY</b> Our in vitro model of calcific aortic valve disease shows an interaction between the hyaluronic acid binding protein CD44 with the osteogenic factor OPN as a potential mechanism of aortic valve calcification. 30951363 2019
CUI: C0598608
Disease: Hyperhomocysteinemia
Hyperhomocysteinemia
0.010 Biomarker disease BEFREE We found that impaired autophagy, as evidenced by decreased levels of MAP1LC3B II/MAP1LC3B I, has a vital role in HHcy-induced human aortic (HA)-VSMC phenotypic switching, with a decrease in contractile proteins (SM α-actin and calponin) and an increase in osteopontin. 31028566 2019
Neuropsychiatric Systemic Lupus Erythematosus
0.010 Biomarker disease BEFREE OPN full in CSF could be a novel diagnostic marker for NPSLE. 30744522 2019
CUI: C0852949
Disease: Arteriopathic disease
Arteriopathic disease
0.010 Biomarker group BEFREE Altogether, these data support that human OPN isoforms may represent novel therapeutic targets to improve neovascualrization and preserve tissue function in patients with obstructive artery diseases. 29959420 2019
CUI: C0878544
Disease: Cardiomyopathies
Cardiomyopathies
0.010 Biomarker group BEFREE The purpose of this study was to identify potential OPN targets in biopsies of HF patients, healthy control subjects, and human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), and to characterize the cardiac phenotype of Col4a3<sup>-/-</sup> mice, relate this to HFpEF, and investigate possible causative roles for OPN in driving the cardiomyopathy. 31146816 2019
Arteriovenous Malformations, Cerebral
0.010 Biomarker group BEFREE OPN and MMPs have been studied in brain arteriovenous malformation (BAVM) patients' tissues and blood samples before intervention. 31275742 2019
Transfusion-Related Acute Lung Injury
0.010 Biomarker disease BEFREE Using pulmonary immunohistochemistry, OPN could be specifically detected in the lungs of mice that suffered from TRALI. 31076444 2019
CUI: C1142152
Disease: Heart valve calcification
Heart valve calcification
0.010 AlteredExpression disease BEFREE Serum osteopontin level is associated with heart valve calcification in HD patients, but there was no relationship found with FGF-23. 30369401 2019
CUI: C1384584
Disease: Generalized osteoarthritis
Generalized osteoarthritis
0.010 Biomarker disease BEFREE Genes involved in bone formation and mineralization, such as osteopontin (OPN) and Matrix Gla protein (MGP), could also be related with OA. 29777408 2019
Cerebral Amyloid Angiopathy, Hereditary
0.010 Biomarker disease BEFREE We propose that calcification of CAA vessels in the observed HCHWA-D cases may be induced by extracellular OPN trapped in the fibrotic Col1 vessel wall, independently of the presence of vascular amyloid. 30868685 2019
CUI: C1519665
Disease: Tumor-Associated Process
Tumor-Associated Process
0.010 AlteredExpression phenotype BEFREE We noticed Secreted phosphoprotein 1 (SPP1) as one of the signature genes up-regulated in HCC tissues with a close relation to the tumor process. 31814897 2019